Piperacillin-tazobactam and nephrotoxicity: Myth busted?
作者信息
Khan Muhammad Momin, Maheshwari Kundan Kumar, Rajput Maisam Ali, Siddiqui Farina Fatima
机构信息
Department of General Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan.
出版信息
Indian J Pharmacol. 2024 Sep 1;56(5):363-364. doi: 10.4103/ijp.ijp_113_24. Epub 2024 Dec 16.
Abstract
摘要
相似文献
1
Piperacillin-tazobactam and nephrotoxicity: Myth busted?
Indian J Pharmacol. 2024 Sep 1;56(5):363-364. doi: 10.4103/ijp.ijp_113_24. Epub 2024 Dec 16.
2
Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
Pharmacotherapy. 2014 Jul;34(7):670-6. doi: 10.1002/phar.1442. Epub 2014 May 22.
3
Does Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity when Used with Vancomycin: A Meta-Analysis of Observational Trials.
Curr Drug Saf. 2017;12(1):62-66. doi: 10.2174/1574886311666161024164859.
4
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
Clin Infect Dis. 2023 Feb 8;76(3):e1444-e1455. doi: 10.1093/cid/ciac670.
5
Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy.
JAC Antimicrob Resist. 2024 Jan 22;6(1):dlad157. doi: 10.1093/jacamr/dlad157. eCollection 2024 Feb.
6
Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.
Ann Pharmacother. 2018 Jul;52(7):639-644. doi: 10.1177/1060028018757497. Epub 2018 Feb 14.
7
Evaluating the Nephrotoxicity of Area-under-the-Curve-Based Dosing of Vancomycin with Concomitant Antipseudomonal Beta-Lactam Antibiotics: A Systematic Review and Meta-Analysis.
Medicina (Kaunas). 2023 Mar 31;59(4):691. doi: 10.3390/medicina59040691.
8
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective Study.
Clin Ther. 2021 Nov;43(11):1910-1920.e3. doi: 10.1016/j.clinthera.2021.09.007. Epub 2021 Oct 9.
9
Nephrotoxicity of teicoplanin-based combination therapy: focus on piperacillin/tazobactam and other anti-pseudomonal β-lactams.
J Antimicrob Chemother. 2021 Jan 19;76(2):499-506. doi: 10.1093/jac/dkaa458.
10
Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumonia.
J Infect Chemother. 2013 Oct;19(5):909-15. doi: 10.1007/s10156-013-0605-x. Epub 2013 May 5.
本文引用的文献
1
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial.
JAMA. 2023 Oct 24;330(16):1557-1567. doi: 10.1001/jama.2023.20583.
2
Mechanisms of Piperacillin/Tazobactam Nephrotoxicity: Piperacillin/Tazobactam-Induced Direct Tubular Damage in Mice.
Antibiotics (Basel). 2023 Jun 28;12(7):1121. doi: 10.3390/antibiotics12071121.
3
Electrolyte Disorders Associated with Piperacillin/Tazobactam: A Pharmacovigilance Study Using the FAERS Database.
Antibiotics (Basel). 2023 Jan 24;12(2):240. doi: 10.3390/antibiotics12020240.
4
Nephrotoxicity from Vancomycin Combined with Piperacillin-Tazobactam: A Comprehensive Review.
Am J Nephrol. 2021;52(2):85-97. doi: 10.1159/000513742. Epub 2021 Mar 18.
5
OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam.
Int J Pharm. 2018 Feb 15;537(1-2):172-182. doi: 10.1016/j.ijpharm.2017.12.037. Epub 2017 Dec 23.
Zotero 插件